GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Suven Life Sciences Ltd (NSE:SUVEN) » Definitions » E10

Suven Life Sciences (NSE:SUVEN) E10 : ₹1.36 (As of Dec. 2024)


View and export this data going back to 2003. Start your Free Trial

What is Suven Life Sciences E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Suven Life Sciences's adjusted earnings per share data for the three months ended in Dec. 2024 was ₹-1.790. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₹1.36 for the trailing ten years ended in Dec. 2024.

During the past 12 months, Suven Life Sciences's average E10 Growth Rate was -49.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2025-04-05), Suven Life Sciences's current stock price is ₹128.72. Suven Life Sciences's E10 for the quarter that ended in Dec. 2024 was ₹1.36. Suven Life Sciences's Shiller PE Ratio of today is 94.65.

During the past 13 years, the highest Shiller PE Ratio of Suven Life Sciences was 100.07. The lowest was 10.58. And the median was 28.76.


Suven Life Sciences E10 Historical Data

The historical data trend for Suven Life Sciences's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Suven Life Sciences E10 Chart

Suven Life Sciences Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 3.58 2.48

Suven Life Sciences Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.69 2.48 2.27 1.95 1.36

Competitive Comparison of Suven Life Sciences's E10

For the Drug Manufacturers - Specialty & Generic subindustry, Suven Life Sciences's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Suven Life Sciences's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Suven Life Sciences's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Suven Life Sciences's Shiller PE Ratio falls into.


;
;

Suven Life Sciences E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Suven Life Sciences's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=-1.79/158.3229*158.3229
=-1.790

Current CPI (Dec. 2024) = 158.3229.

Suven Life Sciences Quarterly Data

per share eps CPI Adj_EPS
201309 3.594 91.042 6.250
201312 2.875 91.425 4.979
201403 2.552 91.425 4.419
201406 2.737 94.103 4.605
201409 1.963 96.780 3.211
201412 2.516 96.780 4.116
201503 1.161 97.163 1.892
201506 1.465 99.841 2.323
201509 1.788 101.753 2.782
201512 1.281 102.901 1.971
201603 2.681 102.518 4.140
201703 2.921 105.196 4.396
201803 9.720 109.786 14.017
201806 1.880 111.317 2.674
201809 0.276 115.142 0.380
201812 -1.041 115.142 -1.431
201903 -2.857 118.202 -3.827
201906 -1.889 120.880 -2.474
201909 -1.437 123.175 -1.847
201912 -1.649 126.235 -2.068
202003 -1.852 124.705 -2.351
202006 -0.756 127.000 -0.942
202009 -1.133 130.118 -1.379
202012 -1.769 130.889 -2.140
202103 -1.567 131.771 -1.883
202106 -2.838 134.084 -3.351
202109 -2.046 135.847 -2.385
202112 -2.500 138.161 -2.865
202203 -1.540 138.822 -1.756
202206 -1.120 142.347 -1.246
202209 -1.590 144.661 -1.740
202212 -2.900 145.763 -3.150
202303 -1.268 146.865 -1.367
202306 -1.100 150.280 -1.159
202309 -0.580 151.492 -0.606
202312 -1.920 152.924 -1.988
202403 -1.220 153.035 -1.262
202406 -1.290 155.789 -1.311
202409 -2.270 157.882 -2.276
202412 -1.790 158.323 -1.790

Add all the adjusted EPS together and divide 10 will get our e10.


Suven Life Sciences  (NSE:SUVEN) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Suven Life Sciences's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=128.72/1.36
=94.65

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Suven Life Sciences was 100.07. The lowest was 10.58. And the median was 28.76.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Suven Life Sciences E10 Related Terms

Thank you for viewing the detailed overview of Suven Life Sciences's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Suven Life Sciences Business Description

Traded in Other Exchanges
Address
Avenue 7, Road No. 5, Banjara Hills, Number 8-2-334, 6th Floor, SDE Serene Chambers, Hyderabad, TG, IND, 500 034
Suven Life Sciences Ltd is an India-based biopharmaceutical company. The company is focused on the acquisition, development, and commercialization of novel therapeutics for the treatment of neurodegenerative disorders. The company's only segment is providing Research and Development services. The company's geographical segment includes India; the USA; Europe and Others. The company generates maximum revenue from the USA. The company earns revenue from the sale of New Chemical Entity (NCE) based Intermediates for CNS disorders.

Suven Life Sciences Headlines

No Headlines